Nanotech Investing CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025
nanotech investing Dr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical Advisor
nanotech investing CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer
